We discovered that the expression levels of RBM39 in all tumours were positively correlated with the expression levels of methyltransferases, as shown in Figure S5B, implying that RBM39 may play a role in carcinogenesis and progression by modulating the epigenetic status of human pan‐cancer. Here, RBM39 is linked to cancer.